News & Updates
Filter by Specialty:
Immunotherapy, TACE-based regimen may reshape HCC treatment landscape
In the EMERALD-1 trial, durvalumab plus bevacizumab (D+B) combined with transarterial chemoembolization (TACE) improved progression-free survival (PFS) in individuals with unresectable hepatocellular carcinoma (HCC) eligible for embolization.
Immunotherapy, TACE-based regimen may reshape HCC treatment landscape
13 Feb 2024
IV ginkgo may boost brain recovery after stroke
In a placebo-controlled trial, active components of Ginkgo biloba given intravenously for 14 days helps improve cognitive recovery among patients following an acute ischaemic stroke.
IV ginkgo may boost brain recovery after stroke
13 Feb 2024
Intensive lifestyle intervention reduces long-term variability in blood sugar, lipids
For people with overweight or obesity and type 2 diabetes, intensive lifestyle intervention appears to minimize the spikes and drops in cardiovascular risk factors such as blood glucose and lipids.
Intensive lifestyle intervention reduces long-term variability in blood sugar, lipids
11 Feb 2024
Cardiogenic shock ups risk of death in hospitalized children with ADHF
Nearly one in four children hospitalized for acute decompensated heart failure (ADHF) had cardiogenic shock (CS), which may lead to death, reports a study.
